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ABSTRACT 
Background: Escherichia coli is a bacterial species that is most frequently associated with urinary tract infections (UTIs) 
worldwide. Recurrent UTIs (RUTIs) pose a major threat to health, especially in women. However, studies on the 
pathogenic potentials of E. coli isolates associated with RUTIs has yet to be done. The present study was designed to 
characterize the isolates of E. coli from women, suffering from repeated UTIs in Bangladesh.  
Methods: A total of 15 isolates of E. coli, collected from women with RUTIs in the Sylhet city of Bangladesh, were 
analyzed by a series of biochemical and molecular tests.  
Results: The PCR amplification of the mannose-resistant type 1 S-fimbriae gene (sfa1) confirmed all sfa1+ isolates of E. 
coli. In an antibiogram assay, all the isolates of E. coli were found to be completely resistant to at least five of the ten 
commercial antibiotics and drug resistance were found to be correlated with the weight of the RUTIs patient. Analysis of 
the 16S rRNA data of the two most drug-resistant and clinically significant isolates were found to be clustered with the 
drug-resistant UTI-causing E. coli isolates, circulated in India.  
Conclusions: This study could pave the way of RUTIs diagnosis and treatment strategy for women in Bangladesh. 
Keywords: RUTIs; E. coli; sfa1; multidrug-resistant isolates; 16S rRNA gene sequencing; correlation analysis. 
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ABSTRAIT  
Contexte: Escherichia coli est une espèce bactérienne associée le plus fréquemment aux infections urinaires dans le 
monde entier. Les infections urinaires récurrentes (IVU) constituent une menace majeure pour la santé, en particulier 
chez les femmes. Cependant, les études sur le potentiel pathogène des isolats d'E. Coli associés aux RUTI n'ont pas 
encore été réalisées. La présente étude visait à caractériser les isolats d'E. Coli provenant de femmes souffrant 
d'infections urinaires répétées au Bangladesh.  
Méthodes: Au total, 15 isolats d'E. Coli, prélevés chez des femmes atteintes de RUTI dans la ville de Sylhet au 
Bangladesh, ont été analysés par une série de tests biochimiques et moléculaires.  
Résultats: L'amplification par PCR du gène S-fimbriae résistant au mannose (sfa1) a confirmé tous les isolats de sfa1 + 
d'E. Coli. Dans un essai d'antibiogramme, tous les isolats d'E. Coli se sont révélés complètement résistants à au moins 
cinq des dix antibiotiques commerciaux et la résistance aux médicaments s'est avérée être corrélée au poids du patient 
RUTI. L'analyse des données de l'ARNr 16S des deux isolats les plus résistants aux médicaments et cliniquement 
significatifs s'est avérée être regroupée avec les isolats d'E. Coli causant des infections urinaires résistantes aux 
médicaments, diffusés en Inde. Conclusions: Cette étude pourrait ouvrir la voie au diagnostic et à la stratégie de 
traitement des RUTI chez les femmes au Bangladesh.  
Mots-clés: RUTIs; E. coli; sfa1; des isolats multirésistants; Séquençage du gène de l'ARNr 16S; analyse de corrélation. 
 
INTRODUCTION  
Urinary tract infections (UTIs) are the systemic 
bacterial infections that are known to affect the 
urethra, urinary bladder, and kidneys. Females are 
mostly infected due to their anatomical 
arrangement- a shorter urethra, resulting in an 
easier travel by the bacteria (1). Previous studies 
have revealed that around 50–60% of women are 
likely to develop UTIs in their lifetime (2). The 
numerous causative agents, responsible for this 
disease; however, E. coli alone accounts for 80–85% 
of the global UTIs (3, 4). Recurrent urinary tract 
infections (RUTIs) are the reinfections that are 
generally caused by the original bacterial isolates 
at a young age. Frequent sexual intercourse 
increases the chance of getting RUTIs (5). 
Approximately one third of women are found to 
be positive for RUTIs by the same bacteria (6, 7). In 
some cases, RUTIs can be lethal when the bacteria 
persist for a long time in a position (5). 
Drug resistance in E. coli is one of the most 
common barriers for treating UTI patients 
worldwide. However, the problem is more severe 
in countries like Bangladesh due to an improper 
tendency of frequently prescribing antibiotics for 
the treatment of UTIs (8). The multidrug-resistant 
strains of E. coli have been reported to further add 
to the complications in the UTI patients and 
decrease the effectiveness of the treatment (9, 10). 
In addition, patients with RUTIs have been 
reported to have a higher prevalence of 
antimicrobial resistance due to the evolution and 
spread of more virulent strains by various genetic 
mechanisms (11). The frequency of RUTIs caused 
by the multidrug resistant strains of E. coli has 
increased recently and has sparked strong 
attention from the government, medical 
practitioners, and health agencies (12). Therefore, 
regional studies on the patterns of antibiotic 
sensitivity are much needed for selecting proper 
treatment strategies to overcome the massive 
problem of drug resistance. 
Virulence factors play a major role in the 
pathogenicity of E.coli associated RUTI infections. 
The S- fimbriae adhesin (sfa) genes, encoded by sfa 
operon are common in all the types of UTIs found 
to be strongly associated with E.coli pathogenicity 
(13). The sfa gene is associated with UTIs, 
gestational pyelonephritis, recurring cystitis, 
pregnancy complications, and diarrhea (13, 14). 
The isolates of E. coli, especially from the 
uropathogenic (UPEC) and the diffusely adhering 
(DAEC) groups are known to produce this 
virulence factor that mediates the host-pathogen 
interactions (13, 15).  
Recent development in molecular techniques, 
especially the 16S rRNA gene sequencing tool has 
been extensively used for the analysis of bacterial 
species in clinical samples (16, 17). In addition, the 
introduction of computer-aided bioinformatics 
tools in sequence analysis has simplified the 
understanding of the strains that are poorly 
characterized and rarely isolated. Therefore, the 
aim of the present study was the characterization 
and phylogenetic positioning of the isolates of E. 
coli from women with RUTIs, by using the 
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computer-aided bioinformatic analysis of their 16S 
rRNA gene sequences.  
MATERIALS AND METHODS 
Ethics statement 
This work has been conducted in accordance with 
“The Code of Ethics of the World Medical 
Association”. The Graduate Research Ethics 
Committee (GREC) of the School of Life Sciences, 
Shahjalal University of Science and Technology, 
Sylhet 3114, Bangladesh, approved and monitored 
the study. The patients consent data were handled 
according to human privacy rights.  
The collection and culture of the bacterial 
isolates 
A total of 15 isolates of E. coli (E1-E15) were 
collected from three different hospitals: the 
Popular Medical Diagnostic Centre (PMDC), 
Sylhet, Bangladesh, the Jalalabad Ragib-Rabeya 
Medical College and Hospital (JRRMCH), Sylhet, 
Bangladesh, and the MAG Osmani Medical 
College and Hospital (MOMCH), Sylhet, 
Bangladesh from January, 2017 to December, 2017. 
After screening the patient data, samples were 
collected from only those women, who were 
having a history of RUTIs. In addition, other 
information about the patients, including patient 
ID (PID), age, and the types of infection were also 
recorded from the patient consent forms (Table 1). 
Primarily, all the patient samples were inoculated 
onto a chromogenic medium, containing Eosin 
Methylene Blue (EMB) and incubated at 37 °C for 
24 h at the Biochemistry and Microbiology 
laboratory of PMDC, Sylhet, Bangladesh. The 
samples were then transported, at a low 
temperature, to the laboratory for further studies.  
The biochemical characterizations  
All the isolates of E. coli were subjected to several 
biochemical and microbiological tests, following 
the Bergey’s manual for the presumptive 
identification of E. coli (18). The isolates were 
assayed for Gram staining, catalase test, oxidase 
test, oxidative-fermentative (OF) test, H2S 
production test, Methyl Red (MR) test, Voges-
Proskauer (VP) test, citrate test, urease test, gelatin 
test, gas production test, etc. Following these 
biochemical tests, the positive isolates of E. coli 
were preserved and cultured for further 
identifications through the PCR technique. 
The extraction and quantification of genomic 
DNA 
Using a commercial bacterial genomic DNA 
extraction kit (Bio Basic Inc., Markham, Ontario, 
Canada), genomic DNA from the isolates of E. coli 
was extracted. Following the manufacturer’s 
instructions, Proteinase K and RNase A were 
added to remove impurities from the DNA 
samples. Using a lambda (λ) DNA molecular 
weight marker, the quantification of the extracted 
genomic DNA samples was done on an agarose 
gel and considering protein-DNA absorbance 
recorded using NanoDrop UV-Visible 
measurements for nucleic acid (ThermoFisher 
Scientific, 2000c). The DNA was then diluted 
accordingly to make the final concentration 30 
ng/µl. The extracted genomic DNA samples were 
then preserved in an ultrafreezer at –20° C for 
further use.  
The amplification of the sfa gene 
PCR amplification was performed in 50 µL 
reaction mixtures, containing 25 µL of the 
prepared 2X master mixtures (Fermentas, Gene-
RulerTM, USA), 2.5 µL of each of the forward and 
reverse primers (sfaF, 5’-
CTCCGGAGAACTGGGTGCATCTTAC–3’ and 
sfaR 5’- CGGAGGAGTAATTACAAACCTGGCA–
3’), 5 µL of the template DNA (100 ng), and 15 µL 
of nuclease-free water. The PCR conditions were 
optimized as follows: an initial denaturation step 
at 94 °C for 4 min, a denaturation step at 94 °C for 
1 min, an annealing step at 65 °C for 1 min, an 
extension period at 72 °C for 1.5 min, and a final 
extension step at 72 °C for 10 min, followed by 
storage at 4 °C. A total of 35 serial cycles of the 
amplification reaction were performed in a 
MultiGene Gradient Thermal Cycler (Labnet 
International Inc., USA). The PCR products were 
separated by electrophoresis on an agarose gel, 
stained with ethidium bromide solution, and 
visualized in a gel documentation system(8).  
The antibiogram profiles of the isolates of E. coli  
The antibiotic profiles of the E. coli isolates against 
ten commercial antibiotic discs were determined 
by the Kirby-Bauer Disc Diffusion Method (19). 
An aliquot of 30 µL of overnight bacterial cultures 
(106 CFU/mL) was spread on Tryptic Soy Agar 
plates (Micromaster Laboratories Pvt. Ltd., 
Maharashtra, India) and the antibiotic discs were 
placed aseptically onto the culture media, in order 
to observe the antibiogram profiles of all the 
isolates of E. coli. The antibiotic discs, used in this 
study were ampicillin (10 µg/disk), cotrimoxazole 
(10 µg/disk), tetracycline (30 µg/disk), 
erythromycin (15 µg/disk), ciprofloxacin (30 
µg/disk), cephradine (25 µg/disk), gentamicin (10 
µg/disk), streptomycin (10 µg/disk), 
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chloramphenicol (10 µg/disk), and 
sulfamethoxazole (25 µg/disk). After 24 h of 
incubation at 37 °C, the zones of inhibition were 
measured (8). 
The amplification and sequencing of the16S 
rRNA gene  
The amplification of the target sequences of the 
16S rRNA gene specific for the isolates of E. coli 
was carried out following the standard method 
(20). The PCR reaction mixture was prepared in 
the same concentration as that used for the 
amplification of the sfa gene with 2.5 µL of each of 
the universal primers, 27F and 1492R (5’-
AGAGTTTGATCCTGGCTCAG–3’ and 5’-
GGATACCTTGTTACGACTT–3’). For this 
reaction, a total of 30 serial cycles were 
programmed and the PCR parameters were 
adjusted like the previous amplification reaction. 
The amplified full-length PCR products, having a 
size of 1465 bp were visualized in an agarose gel 
and purified with the PureLink PCR Purification 
Kit (Thermo Scientific, Waltham, MA, USA), 
according to the manufacturer’s instructions. The 
purified 16S rRNA PCR products were then 
sequenced from the “1st BASE” sequencing center, 
Malaysia. The raw sequences were extracted, 
edited, assembled, and run for further analysis, 
using the various sequence analysis tools (16).  
Analysis of the 16S rRNA gene sequence data 
and the status of phylogenetic relationship  
According to the antibiogram assay, the two most 
multidrug-resistant isolates of E. coli, E8 and E10—
also associated with other complications in the 
patients such as cystitis, hypertension, and 
pregnancy—were selected for the universal 16S 
rRNA gene sequencing to analyze their 
phylogenetic positions. After sequencing, the raw 
sequences were extracted and assembled using the 
BioEdit (v7.0.4), Chromas (v2.01), and SeqMan Pro 
(v15.0) sequence editing tools.  The web-based 
database, DECIPHER (v9.20), was used to remove 
the chimeras from the raw sequences. Using 
BLASTn in the NCBI database, the edited DNA 
sequences were then run for the homology 
matching of the highly similar sequences. Using 
the ClustalW program in MEGA (v7.0), the 
assembled sequences were aligned and using the 
nearest neighbor method with 1,000 bootstrap 
replicates, a phylogenetic tree was constructed. 
The GenBank accession numbers of the similar 
sequences were indicated in parenthesis to most of 
the E. coli species. The evolutionary divergence 
among the sequences was calculated as the 
Kimura J-Model in MEGA (v7.0). 
Statistical analysis 
Data collected from RUTI patients were plotted in 
corrplot (v0.84) for finding of graphical 
correlations among variables in RStudio of R 
package. A total of 15 observations from four 
variables were tested for Pearson(s) correlation 
(p<0.5), structured in matrix (mat) form, then 
mixed (corrplot.mixed) and finally visualized 
using color method where blue signified positive 
correlations and red demonstrated negative 
correlations. 
RESULTS 
The biochemical characterization of the isolates 
of E. coli  
Although all the isolates were initially supplied as 
E. coli in the EMB agar medium, the specific details 
of the morphological and biochemical 
characterizations confirmed that all of them 
belonged to the same species. The results showed 
isolates were positive for catalase, indole, methyl-
red, and motility tests while the alpha-hemolysin 
producing assay exhibited partial lysis of the 
sheep blood agar and appeared greenish in color 
following overnight incubation. The isolates were 
negative for Gram’s test, oxidase, voges-proskauer 
tests; couldn’t utilize citrate, urease, gelatin and 
H2S for production of gas.   
The amplification of the sfa gene in the isolates 
of E. coli by PCR 
In the PCR amplification, all the 15 E. coli isolates 
were positive for the sfa gene and gave an 
expected product size of 410 bp upon visualization 
on the agarose gel. The results of the PCR 
amplification of the sfa gene in the isolates of E. 
coli, collected from RUTIs women are shown in 
Figure 1.  
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FIGURE 1: PCR AMPLIFICATION OF AFA1 GENES IN E. COLI  ISOLATES. ALL OF THE ISOLATES WERE 
POSITIVE FOR SFA1 AND SHOWED 410 BP PCR PRODUCTS ON AGAROSE GEL. 
 
The antibiotic sensitivities of the isolates of E. 
coli  
Among the ten antibiotics tested by the Kirby-
Bauer Disc Diffusion Assay, all the isolates of E. coli 
were completely resistant to ampicillin (AMP), 
erythromycin (ERY), streptomycin (STP), 
sulfamethoxazole (SXT), and tetracycline (TET). 
Out of 15 isolates, five (E2, E5, E8, E9, E10) were 
resistant to gentamicin (GEN) and cephradine 
(CEP) and two (E8, E10) displayed resistance to 
cotrimoxazole (COT). The isolate E8 showed 
sensitivity to only ciprofloxacin (CIP) and E10 was 
inhibited by chloramphenicol (CPL) and 
ciprofloxacin (CIP). 
  
TABLE 1: LIST OF SAMPLES AND INFORMATION 
E. coli isolates Age No. of antibiotic resistance (out 
of 15) 
Weight Sources 
E1 37 6 56 1* 
E2 40 7 48 2† 
E3 34 5 52 3k 
E4 40 6 58 1* 
E5 35 7 50 1* 
E6 33 6 54 2† 
E7 38 6 49 2† 
E8 35 9 62 1* 
E9 43 7 58 3k 
E10 33 8 60 2† 
E11 36 6 52 1* 
E12 42 6 54 1* 
E13 45 6 53 2† 
E14 48 5 50 2† 
E15 40 6 56 3k 
 
Footnotes: *Popular Medical and Diagnostic Centre, Sylhet, Bangladesh; †Jalalabad Ragib-Rabeya Medical College and 
Hospital, Sylhet, Bangladesh; kMAG Osmani Medical College and Hospital, Sylhet, Bangladesh. 
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The amplification of the universal 16S rRNA 
gene sequences  
The genomic DNA of the isolates of E. coli was 
used to amplify the universal 16S rRNA gene 
sequences by PCR. The multidrug resistant and 
complications-associated isolates, E8 and E10, 
were amplified by the universal amplification 
primers, 27F and 1492R. Both the isolates gave 
positive amplifications and displayed an expected 
product size of 1465 bp on the agarose gel. 
Analysis of the 16S rRNA gene sequences of the 
multidrug-resistant isolates of E. coli  
In the NCBI database, BLASTn of the assembled 
sequences of the E. coli isolates, E8 and E10, 
showed 99.0% homology to the sequences of the E. 
coli isolates, extracted from clinical samples. The 
evolutionary divergence score revealed no 
significant distances (0.000) among the isolates in 
the present study and the two most recent UTI-
causing strains of E. coli (IBB1 and U744) are 
circulating in India since August 2017. However, 
evolutionary distances were found to exist among 
the study isolates and the other strains, previously 
circulating in countries such as Pakistan and the 
USA (0.001–0.002). The phylogenetic tree also 
supported the close relationship of the four 
strains—E8, E10, IBB1, and U744, circulating in 
2017, according to the cluster they formed (Figure 
2). The outgroup bacteria, Klebsiella pneumoniae, 
were positioned in a completely separate cluster in 
the phylogenetic tree and had significant 
evolutionary distances with the study isolates 
(0.048). The sequences of the isolates of the present 
study are now available at the NCBI database 
under the GenBank accession numbers, 
MG857840.1 (E. coli strain E8) and MG857757.1 (E. 
coli strain E10). 
 
FIGURE 2:. CORRELATION MATRIX PLOT SHOWED ASSOCIATION AMONG OBSERVATIONS. DRUG 
RESISTANCE WERE FOUND TO HAVE AN ASSOCIATION WITH WEIGHT BUT INDEPENDENT OF AGE AND 
SOURCES (HOSPITALS). 
 
Correlations among variables 
Among four variables, antibiotic resistance was 
found to be positively correlated (+0.57) with the 
weight of the RUTIs patients. The variables for 
antibiotic resistance pattern were independent of 
patient’s age and sources of sample collection 
while the correlation between age and sources was 
insignificant to perspectives of the present study 
(Figure 3). 
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FIGURE 2: THE PHYLOGENETIC RELATIONSHIP OF E. COLI STRAINS E8 AND E10, ON THE BASIS OF 16S RRNA 
SEQUENCES, WITH THE E. COLI ISOLATES CAUSING UTI IN OTHER PARTS OF THE WORLD.  
The evolutionary history was inferred using the neighbor-joining method.  The percentage of replicate trees in which the 
associated taxa clustered together in the bootstrap test (1000 replicates) are shown next to the branches. all 
positions containing gaps and missing data were eliminated. Klebsiella pneumoniae signifies an outgroup 
bacteria in the tree. evolutionary analyses were conducted in mega7. 
 
DISCUSSION                                                                                                                                                                                     
The accumulation of the multidrug-resistant 
clinical isolates results in significant health 
challenges worldwide, especially in women. 
Particularly in low-income countries, the 
prevalence and occurrence of the multidrug-
resistant isolates of E. coli are much higher and 
more common (4). Previous studies have revealed 
that 69% of the UTIs are caused by E. coli in 
Bangladesh, where 83–85% of the infected patients 
are females (21, 22). Although many of these 
women have faced RUTIs in their lifetime, most of 
them were literally unaware of their reinfections 
(5). Currently, no clinical data about the 
percentages of women, suffering from RUTIs in 
Bangladesh are available because of the improper 
diagnostic and treatment strategies. Hence, we 
found only seven isolates of E. coli after 12 months 
of screening across three different hospitals. Due
to the frequent use of antibiotics and rupture in 
the antibiotic dose regimens, the clinical isolates of 
E. coli have recently emerged as multidrug-
resistant variants all over the country, thereby 
making the treatment of UTIs and RUTIs 
challenging (21, 23). Previous studies have 
discovered the failure of the commercial 
antibiotics against the clinical isolates of E. coli in 
the major cities of Bangladesh, including Dhaka, 
Rajshahi, and Sylhet, where 50–70% of drug 
resistance was noticed from 2010–2015 (24, 25). 
The present study found no effective agent that 
can potentially inhibit all the isolates of E. coli. Our 
results revealed that the pattern of drug resistance 
was increasing very rapidly in Bangladesh and 
varied even within a city, where drug resistance to 
the UTI-causing isolates of E. coli increased by 
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approximately 5–10% in every five years (23). 
Therefore, a careful use of the commercial 
antibiotics needs to be executed through 
appropriate monitoring systems only after a 
proper diagnosis of bacteria, in order to minimize 
the spread of the drug-resistant isolates.  
In Bangladesh, the diagnosis of the isolates of E. 
coli from the UTI patients depends solely on the 
EMB Agar Base plate culture method, which often 
gives false positive results and requires significant 
technical skills, in order to confirm the bacteria 
(26). Although the 16S rRNA gene sequencing 
method is routinely used alongside plate-based 
screening for the analysis of bacterial sequences 
and phylogenetic relationship, the details of the 
virulence properties, molecular characterizations, 
and phylogenetic analysis, using PCR and the 16S 
rRNA gene sequencing tools are yet to be 
undertaken in Bangladesh. The detection of 
virulence factors is always a key aspect in 
analyzing the pathogenicity of any bacterial isolate 
because these factors act multifunctional (27). In 
the present study, we found very high frequency 
of the sfa gene in the hospitalized RUTIs patients, 
where all the isolates were positive in PCR 
amplification. Previous studies have concluded 
that more than 50% of the sfa1+ isolates of E. coli in 
the UTIs have a high prevalence of virulence 
factors and pose a serious threat to the health of 
the patients (28). Adhesion and fimbrial virulence 
factors in E. coli such as sfa, afa, fim, etc., cause 
further risks in the development of RUTIs, 
especially in women (29). In 13 years (2002-2015), 
studies found approximately 13% increase of sfa 
prevalence in E. coli causing UTI (13). In contrast 
to the previous studies, our study revealed that 
the sfa gene frequencies are much higher (100%) in 
the Eastern part of Bangladesh and is probably 
responsible for other complications in women. In 
phylogenetic studies, the E. coli isolates in the 
present study clustered very closely to the E. coli 
strains found in India in 2017, suggesting the same 
evolutionary origin for these bacteria. The 
changing phylogenetic position of the isolates of E. 
coli each year indicates the accumulation of the 
more multidrug-resistant isolates in South Asia. 
Similar to the E. coli isolates, E8 and E10, the 
multidrug-resistant strains, IBB1 and U774 were 
also characterized from the chronic UTI patients 
and had a number of virulence factors (30, 31). In 
addition to drug resistance, obesity also increases 
the risk of RUTIs infection in women. One study 
revealed significant correlation of obesity with 
RUTIs (p<0.001) where fatness increases the risk of 
recurrent infections in women by 27% and drug 
resistance by 20% (32). In present study, the 
association between weight and drug resistance 
also significant compared to other variables. Thus, 
the overall trend and pathogenicity of the drug-
resistant isolates of E. coli are truly alarming in 
Southeast Asia for the upcoming days. 
CONCLUSION: In this comprehensive study, we 
effectively used the various traditional and 
molecular biology tools for the precise 
identification and analysis of the isolates of E. coli 
from women with RUTIs in the eastern part of 
Bangladesh that can be used for the further 
molecular analysis of these isolates, associated 
with UTIs and RUTIs in Bangladesh. 
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